Putting the patient at the heart of healthcare
Our Chief Executive Clare Pelham spoke passionately about the need to keep patients front and centre when she appeared on a panel at the New Statesman’s Future of Healthcare conference in London at the end of October.
Changes to free prescriptions will not affect people with epilepsy
The Epilepsy Society can confirm that proposed changes to the UK's provision of free prescriptions will not affect people with epilepsy.
Survey about the anti-seizure medication topiramate
Are you taking topiramate for your seizures or perhaps for the prevention of migraine or headaches? The UK medicines regulator – the MHRA – has launched a survey to understand more about people’s experience of the seizure medication, topiramate.
Lessons to be learned from maternal deaths report
A report released two weeks ago looked at the data behind over 500 women who died during or up to a year following pregnancy in the UK and Ireland in 2019-2021, from causes including epilepsy.
Valproate must now be dispensed in original packaging
A new change in regulations means that all valproate containing medications must now be dispensed in the manufacturer’s original full packaging.
New training course equips universities with the know-how for supporting students with epilepsy
We recently ran an epilepsy awareness course for higher education institutions.